Sarcoidosis is a multisystem (involves the entire body) granulomatous (small growths or lumps) disease that produces inflammation or swelling of the tissues in any part of the body.
In 90 percent of the diagnosed cases, the inflammation is in the lungs and is called pulmonarysarcoidosis.
People with sarcoidosis may have no symptoms, only vague symptoms (such as weight loss, fever and a general "ill feeling"), or symptoms associated with a specific organ(s).
Sarcoidosis is a fairly common disease with an annual incidence rate of approximately 11 per 100,000 in Caucasians and approximately 36 per 100,000 African Americans in the United States.
Sarcoidosis is a disease of unknown etiology characterized by granuloma formation in a variety of organs.
Sarcoidosis is characterized by the formation of small, granular inflammatory lesions (granulomas).
Sarcoidosis in fls is more extensive and symptomatic, whereas in whites it tends to be asymptomatic, and limited.
Sarcoidosis does not cause diabetes, but prednisone, used for treating sarcoidosis, may cause diabetes in those patients who are predisposed to develop diabetes.
Sarcoidosis is common in the south and southeast; a lot of research is being done to find out the cause and distribution of sarcoidosis.
www.sarcoidosissharma.com /pages/6 (5900 words)
Sarcoidosis(Site not responding. Last check: 2007-10-15)
It is thought that sarcoidosis of the lungs begins with alveolitis (inflammation of the alveoli), the tiny sac like air spaces in the lungs where carbon dioxide and oxygen are exchanged.
The lungs of sarcoidosis patients cannot handle these tasks as well as they should; this is because granulomas and fibrosis of lung tissue decrease lung capacity and disturb the normal flow of gases between the lungs and the blood.
Sarcoidosis is now believed to be associated with a complex mix of immunological disturbances involving simultaneous activation, as well as depression, of certain immunological functions.
In order to characterize sarcoidosis in older patients, the clinical, radiographic and laboratory features of sarcoidosis presenting in patients aged 50 or older were compared to patients whose sarcoidosis was diagnosed at an earlier age.
We report here the case of a 46-year-old woman presenting with multisystem sarcoidosis 12 months after the completion of combined treatment for stage III squamous cell carcinoma of the uterine cervix; at the time she was still in complete remission of the tumor.
Papular sarcoidosis of the knees: a clue for the diagnosis of erythema nodosum-associated sarcoidosis.
Sarcoidosis occurs mainly in persons aged 20 to 40 yr and is most common in Northern Europeans and American fls.
In one study, recovery was observed on x-ray at the end of 5 yr in 82% of Swedish patients with hilar adenopathy alone and in 57% of patients with pulmonary opacities.
Race and extrapulmonary sarcoidosis help predict the likelihood of recovery in patients with pulmonarysarcoidosis: 89.4% in whites with no extrathoracic disease; 69.7% in whites with extrathoracic disease; 76% in fls with no extrathoracic disease; and 46.4% in fls with extrathoracic disease.
eMedicine - Sarcoidosis : Article by Ramy Yakobi, MD, MBA(Site not responding. Last check: 2007-10-15)
Sarcoidosis is a chronic noncaseating granulomatous disease of unknown etiology that affects many organs and tissues, most commonly the lungs.
Because sarcoidosis is a multiorgan disease, patients may complain of a variety of symptoms that may complicate diagnosis.
A suspension from the spleen or a lymph node of a patient with a confirmed diagnosis of sarcoidosis is injected intradermally into a patient suspected to be affected by the disease.
No markers have been identified as indicating how sarcoidosis is going to behave in any individual or how an individual with sarcoidosis is going to respond to treatment, although a physician experienced with sarcoidosis may be able to make a "good guess" based on his or her experience.
Sarcoidosis of the lungs is usually diagnosed using chest x-rays, pulmonary function tests, blood tests, and bronchoscopy with lung biopsy.
For sarcoidosis of the skin or eyes, the treatment is topical (as a cream or ointment), although injection of steroids into the eye may be needed if serious iritis or uveitis is found.
Sarcoidosis is a disease which can affect many organs within the body.
In addition to having no clear-cut understanding of the cause of sarcoidosis, researchers are also puzzled by its distribution in the world population.
Sarcoidosis affects both men and women, although women are more likely to have the disorder.
The Image of Sarcoidosis(Site not responding. Last check: 2007-10-15)
Sarcoidosis is a multisystem granulomatous disease of unknown etiology.
Sarcoidosis has a higher frequency in people of color and in women, but the disease is also common in whites and men in the U.S. and throughout the world.
Sarcoidosis does occur in children and elderly, but most patients present between ages 20-40 years.
Sarcoidosis -- familydoctor.org(Site not responding. Last check: 2007-10-15)
Sarcoidosis (say "sar-coy-doe-sis") is a disease that may affect any organ or system in the body.
Sarcoidosis is most common in adults between 20 and 40 years of age.
Sarcoidosis affects the liver at some point in approximately 20% of people who have the disease.
familydoctor.org /320.xml (823 words)
[No title](Site not responding. Last check: 2007-10-15)
"The prevalence of hepatic granulomas in sarcoidosis is 65%.
Sarcoidosis has developed in non-sarcoidosis transplant recipients who have recieved tissues or organs from donors who were not suspected or known to have active sarcoidosis.
Sarcoidosis is a chronic progressive disease that is rarely diagnosed in its early stages.
Sarcoidosis is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH).
This means that Sarcoidosis, or a subtype of Sarcoidosis, affects less than 200,000 people in the US population.
Various sources and calculations are available in statistics about Sarcoidosis, prevalence and incidence statistics for Sarcoidosis, and you can also research other medical statistics in our statistics center.
Sarcoidosis challenges that statement and makes us aware of more.......difficulty in breathing, pain, fever, fatigue, moods, and other senses that many people with chronic illnesses have to cope with.
Sarcoidosis is a mysterious, powerful, and often systematic disease.
To the Social Security Administrations, sarcoidosis is a disease not understood, showing symptoms to be mild or absent.
The Sarcoidosis Center is a non-profit corporation (501 (c)(3)) designed to provide information for patients and physicians regarding sarcoidosis.
Through improved communication, closer ties can be established and a directory of physicians who care for sarcoidosis patients may also be developed and shared among groups.
The major purpose of the site is to provide assistance for patients with sarcoidosis including educational as well as supportive services.